Niall Anthony Gallen
Keine laufenden Positionen mehr
Profil
Niall Anthony Gallen is a former Director at Glyconics Ltd.
from 2017 to 2022.
Prior to that, he worked as the Chief Optical Engineer at Screen Technology Ltd.
Dr. Gallen holds a graduate degree from Queen's University of Belfast, an undergraduate degree from Trinity College Dublin, and a doctorate degree from the University of Sussex.
Ehemalige bekannte Positionen von Niall Anthony Gallen
Unternehmen | Position | Ende |
---|---|---|
Glyconics Ltd.
Glyconics Ltd. Medical SpecialtiesHealth Technology Glyconics Ltd. develops medical devices for COPD and provides diagnostic testing services. The company was founded on October 22, 2013 and is headquartered in Norwich, the United Kingdom. | Direktor/Vorstandsmitglied | 24.11.2022 |
Screen Technology Ltd.
Screen Technology Ltd. Electronic Equipment/InstrumentsElectronic Technology Screen Technology Ltd. used to provide display solutions for large and high resolution display screens. The company was founded in 1995 and was headquartered in Ely, the United Kingdom. | Corporate Officer/Principal | - |
Ausbildung von Niall Anthony Gallen
Trinity College Dublin | Undergraduate Degree |
Queen's University of Belfast | Graduate Degree |
University of Sussex | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Screen Technology Ltd.
Screen Technology Ltd. Electronic Equipment/InstrumentsElectronic Technology Screen Technology Ltd. used to provide display solutions for large and high resolution display screens. The company was founded in 1995 and was headquartered in Ely, the United Kingdom. | Electronic Technology |
Glyconics Ltd.
Glyconics Ltd. Medical SpecialtiesHealth Technology Glyconics Ltd. develops medical devices for COPD and provides diagnostic testing services. The company was founded on October 22, 2013 and is headquartered in Norwich, the United Kingdom. | Health Technology |